Description
Orforglipron Research Compound
Orforglipron Reasearch Compound, also known by the research identifier LY3502970, is a synthetic small-molecule compound intended for controlled laboratory research.
Unlike peptide-based research materials, Orforglipron is a non-peptide heterocyclic molecule. It does not contain a conventional amino-acid sequence and should therefore be classified separately from peptide products on the LV Longevity Peptides website.
Its chemical identity is defined by its molecular structure, molecular formula, molecular weight, CAS number, and analytical characteristics rather than by a peptide sequence.
Orforglipron has been characterized in public chemical databases as a non-peptide small molecule associated with GLP-1 receptor research.
Orforglipron Chemical Identity
Current PubChem data identifies the parent compound as:
| Specification | Information |
|---|---|
| Product Name | Orforglipron |
| Alternate Identifier | LY3502970 / LY-3502970 |
| Compound Type | Synthetic small molecule |
| Chemical Type | Non-peptide heterocyclic compound |
| Molecular Formula | C₄₈H₄₈F₂N₁₀O₅ |
| Molecular Weight | 883.0 g/mol |
| CAS Number | 2212020-52-3 |
| PubChem CID | 137319706 |
| Peptide Sequence | Not applicable |
PubChem currently reports the molecular formula as C₄₈H₄₈F₂N₁₀O₅ and molecular weight as 883.0 g/mol.
Important Chemical-Form Note
Orforglipron can also appear in different salt/associated forms in chemical databases, including hydrochloride and calcium forms. Those forms have different molecular formulas and molecular weights.
Research Applications
Orforglipron can be positioned for controlled non-clinical laboratory research, including:
- Small-molecule characterization
- Analytical method development
- Structure–property relationship research
- Controlled biochemical assay systems
- Receptor-related molecular research
- Comparative analysis of synthetic small molecules
- In-vitro evaluation of small-molecule behavior
- Chemical and structural characterization
Orforglipron and GLP-1 Research
Orforglipron is a non-peptide GLP-1 receptor agonist rather than a peptide analogue. Public chemical databases identify it as an orally active, non-peptide GLP-1 receptor compound.
Orforglipron is a small-molecule GLP-1 receptor research compound, not a GLP-1 peptide.
This is especially useful because users may search for Orforglipron alongside peptide-based GLP-1 compounds.
Avoid converting receptor activity into claims about:
- Weight loss
- Diabetes treatment
- Appetite suppression
- Obesity treatment
- Blood glucose control
- Medical benefits
Why Orforglipron Is Not a Peptide
Small Molecule vs. Peptide
Orforglipron does not consist of linked amino acids and therefore has:
- No peptide sequence
- No peptide molecular architecture
- No amino-acid sequence to report
Chemical Information:
- Chemical Name: Orforglipron
- Alternate Identifier: LY3502970
- Molecular Formula: C48H48F2N10O5
- Molecular Weight: ~886.95 g/mol
- Compound Class: Synthetic small-molecule research compound
- Chemical Type: Non-peptide heterocyclic small molecule
Molecular Structure
FAQ
What is Orforglipron?
Orforglipron, also known as LY3502970, is a synthetic non-peptide small-molecule compound used in research involving GLP-1 receptor biology and related molecular systems.
Is Orforglipron a peptide?
No. Orforglipron is a synthetic small molecule rather than an amino-acid peptide. It therefore does not have a conventional peptide sequence.
What is another name for Orforglipron?
A commonly used development identifier is LY3502970, also written LY-3502970.
What is the molecular formula of Orforglipron?
The parent compound is listed with the molecular formula C₄₈H₄₈F₂N₁₀O₅.
What is the molecular weight of Orforglipron?
PubChem currently reports approximately 883.0 g/mol for the parent compound. Different salt or associated forms can have different molecular weights.
What is the CAS number for Orforglipron?
The parent compound is associated with CAS 2212020-52-3.
Does Orforglipron have a peptide sequence?
No. Orforglipron is a small molecule, so a peptide amino-acid sequence does not apply.
What is Orforglipron studied for?
Orforglipron has been investigated in research involving GLP-1 receptor activity and non-peptide small-molecule pharmacology. For an LV research page, this should be described strictly as research context rather than a therapeutic claim.
